The ABO blood group system was the first human blood group identified.
It is unique because it has naturally occurring antibodies (Abs) without requiring a foreign red blood cell antigen (Ag) to stimulate their production.
ABO Abs, also known as isohemagglutinins, have specificity opposite to the corresponding antigens on the red blood cells (RBCs).
These antibodies are non-red cell stimulated, likely resulting from environmental exposure and are referred to as "EXPECTED" antibodies.
The ABO blood group is highly significant in transfusion practice.
Common isohemagglutinins include Anti-A and Anti-B, which are IgMs that readily activate the normal complement cascade (C').
Transfusion of incompatible RBCs can lead to intravascular hemolysis, potential renal failure, and even death.
Detection of ABO incompatibility is a primary foundation for safe pretransfusion testing; The Joint Commission (TJC) and College of American Pathologists (CAP) proficiency testing (PT) require 100% accuracy in ABO typing tests at all times.
ABO compatibility is also critical in transplant patients.
ABO-incompatible organs may cause acute humoral rejection, that can result in graft rejection/failure [aka, Graft-vs-Host Disease (GVHD)], potentially leading to the recipient's death, depending on the transplanted organ.
Group | Caucasian | African American | Asian | Hispanic | N. Am. Indians |
---|---|---|---|---|---|
O | 45 | 50 | 40 | 56 | 55 |
A | 40 | 26 | 28 | 31 | 35 |
B | 11 | 20 | 25 | 10 | 8 |
AB | 4 | 4 | 7 | 3 | 3 |
The ABO system has 3 common alleles: A, B, and H (O).
Inheritance follows straightforward Mendelian genetics.
Individuals inherit one ABO autosomal gene from each parent.
A, B, and O genes are expressed as codominant; the "O" gene is an amorph, producing no transferase enzyme and resulting in no detectable O antigen.
Rare, mutant alleles exist within the human population.
The ABO locus is on chromosome 9.
A | B | 0 | |
---|---|---|---|
A | AA | AB | AO |
B | AB | BB | BO |
O | AO | BO | OO |
If both parents are type A, can they produce a type O baby?
Answer: Yes. Mom (type A) AA or AO, Dad (type A) AA or AO can have:
Child 1 (type A): AA or AO
Child 2 (type O): OO
Phenotype | Group | Possible Genotype |
---|---|---|
O | HH (OO) | |
A | AA or AO* | |
B | BB or BO* | |
AB | AB |
*When determining possible genotypes, use the heterozygous form of the genes.
ABO Phenotype, Antigen on the RBC, Circulating Antibody in the Plasma
Group O: H (not an O ag) (No A or B ags), Anti-A, Anti-B, Anti-A,B* a single, IgG2 subclass cross-reacting antibody
Group A: A, Anti-B
Group B: B, Anti-A
Group AB: A and B, None
ABH = ABO; "O" blood type contains H ag, i.e., there is no “O” ag.
Antigens are carbohydrate structures.
Specific glycosyl-transferases add individual sugars sequentially to sites on sugar chains on the common precursor substance.
A common precursor substance produces H, A, and B antigens.
Interaction of ABO, Hh, and Sese genes affects antigen expression.
H precursor substance is a 4-sugar chain: Glucose (Glu); Galactose (Gal); N-acetylglucosamine (GlcNAc); Galactose (Gal).
It is primarily of Type 2 chains with beta 1 → 4 linkage on the RBC surface antigen.
H gene (FUT 1 gene)
2 allele system (H & h): HH, Hh, or hh
h is an amorph; h is very rare
Inherited independently of ABO genes
The H gene is required for the production of A or B antigens
H gene produces the α-2-L-fucosyltransferase that adds L-fucose to the precursor substance.
The H antigen is the result of the attached L-fucose (Fuc).
A and B alleles / genes encode for glycosyl-transferases which add sugars to the H antigen.
The A gene produces the α-3-N-acetylgalactosaminyltransferase that adds the GalNAc (N-acetyl-D-galactosamine) sugar to the H antigen.
The B gene produces the α-3-D-galactosyltransferase that adds the Gal (D-galactose) sugar to the H antigen.
When both A and B genes are present to produce the AB phenotype, the B enzyme seems to compete more efficiently for the H antigen than the A enzyme. As a result of this competition, the number of A antigens on the RBC are less than the number of B antigens.
Genes Hh or HH, hh
antigens (rbc) AO or AA, BO or BB, AB, 00
A & H B & H A, B, & H H none detecteced
any combination P.S. P.S.
Over 99.99% of the human population has the H gene.
ABO Types A and B can exist as a "subgroup" which is inherited. Subgroups usually have a lower number of A or B antigens on the RBCs.
The more A and / or B antigens produced, the more H antigen is converted. Thus, the density of H antigen on cells is (from greatest to least amounts): O > A2 > B > A2B > A1 > A1B.
H Genotype | ABO Phenotype | RBC antigens | Expected Plasma Abs |
---|---|---|---|
HH or Hh | A | A, H | Anti-B |
B | B, H | Anti-A | |
AB | A, B, H | None | |
O | H | Anti-A, Anti-B, & Anti-A,B | |
hh (Bombay) | Oh | No A, B, or H | Potent Anti-H, Anti-A, & Anti-B |
H (FUT 1) chromosome 19
Se (FUT 2) chromosome 19
ABO chromosome 9
H
H substance on RBCs
h Silent / Amorph
Se
Secretor; H substance found in secretions
se Non-secretor; Silent / Amorph
A, B
A, B, & H antigens on RBCs, when H is present
A and B in secretions, when Se is present
"O" Silent / Amorph H antigen is present
Se (secretor) locus FUT 2
2 allele system – SeSe, Sese, or sese
Individual (of appropriate ABO group) who has A, B, antigens in gastrointestinal, genitourinary, and respiratory tract secretions, as well as in milk, sweat, tears, & amniotic fluid (NOT in CSF).
Secreted antigens are mostly glycoproteins (mucins), but also can be "free oligosaccharides" in milk & urine.
Se has expression over the se amorph allele
SeSe / Sese ~ 80% secretors of A, B, and / or H
sese ~ 20% nonsecretors
Glycolipids - imbedded in cell membranes
Glycoproteins - secreted into exocrine fluids
Fucosly-transferase adds L-fucose to make H antigen primarily on Type-1 chains
RBC antigens | Soluble Substance | |
---|---|---|
Basic backbone | Glycolipids | Glycoproteins |
Precursor Chain | Type 2 | Type 1 |
Linkage | beta 1→4 | beta 1→3 |
L-fucosyltransferase | (FUT 1) by H gene | (FUT 2) by Se gene |
Secretor Genotype | ABO Phenotype | Antigen | Secreted Antigen |
---|---|---|---|
SeSe or Sese (80%) | A | A, H | A, H |
B | B, H | B, H | |
AB | A, B, H | A, B, H | |
O | H | H | |
Oh | No A, B, H | No A, B, H | |
sese (20%) | A | A, H | No A, B, H |
B | B, H | " | |
AB | A, B, H | " | |
O | H | " | |
Oh | No A, B, H | " |
The hh genotype is called "Bombay" (designated as "Oh")
No L-fucosyl-transferase produced
No H substance / no H antigen
No A or B antigens present on RBCs
Only precursor substance found on RBCs
Cannot produce L-fucosyl-transferase; no H antigen produced - results in RBCs with no H, A, or B antigen.
Bombay RBCs will NOT agglutinate with reagent Anti-A, reagent Anti-B, reagent Anti-A,B or reagent Anti-H (no antigens present); the patient types as an "O".
Bombay people have Anti-A, Anti-B, Anti-A,B, and a potent Anti-H as “naturally occurring” Abs in their plasma.
Agglutinating ALL ABO blood groups. What blood ABO blood group would you use to transfuse this patient??
A1 & A2 both encode for the enzyme α-3-N-acetyl-galactos-aminyl-transferase; puts an immunodominant sugar N-acetyl-D-galactose on H antigen: A1 gene is very potent and produces much more enzyme than the A2 gene.
A1 allele is prevalent over A2
A1A2 genotype → A1 phenotype
A2A2 or A2O genotype → A2 phenotype
Most group A infants "appear to be" A2 at birth - ABH antigens not yet fully developed.
A2 cells do not always react well with Anti-A reagent.
Quantitative differences:
Type # antigens / cell
A1 800,000 - 1,200,000
A2 ≈ 250,000
Qualitative differences:
1 - 8% of A2 people have Anti-A1 in sera
22 -35% of A2B people have Anti-A1 in sera
A1 enzyme transferase is 5-10x more active which converts most of the H antigen to the A1 antigen.
Phenotypic reactions Reactions with:
Anti-A Anti-A1 (lectin)
A1 + +
A2 + -
Frequency of A subgroups
Type % of A types % of all A types (A, AB)
A1 80 33
A2 20 8
<1 % of all A types, e.g., A3, Ax, ABantu, Ael
Most are a result of mutant A allele inheritance
To detect:
Anti-A,B sera obtained / manufactured from O donors
Anti-H
Adsorption-elution tests with Anti-A
Saliva studies for A and H antigens
Monoclonal Ab reagents are commonly used & because of their specificity, it makes weak subgroup reactions nearly irrelevant
Also look for presence of Anti-A1 in the patient sera of A2 & A2B phenotypes.
Subgroups & weak subgroups of B are very rare.
Classified & detected similarly to A subgroups, i.e., absorption- elution technique.
Unlike an A Subgroup, the presence of an "anti-B1" does NOT exist.
A and B genes are "next to each other"
Antigens appear to be inherited together: AB parent + O parent = AB child Normally, what would be the offspring type?
Gene mutations identified resulting in single transferase capable of transferring both GalNAc and Gal.
Patient samples used for Blood Bank testing can be collected in any of these specimen tube types:
Purple top tube (contains RBCs & plasma)
Red top tube (contains serum and a clot)
Pink top tube (contains RBCs & plasma) - considered the official BB specimen
NOTE: To separate serum / plasma from the RBCs, spin specimen tube.
Purple top tube (Hematology specimen)
Contains EDTA (Ethylenediaminetetraacetic acid) in either of 2 forms:
K2 EDTA - dried form coated along sides of plastic specimen tube
K3 EDTA - liquid form found in glass specimen tubes
EDTA binds Ca^{+2} to prevent clotting
Both types of EDTA are used in Hematology for CBCs, differential smears, platelet counts, sed rates, etc.
Red top tube (Chemistry specimen)
Contains no anticoagulant or any additives; just a plain glass or plastic tube; blood will clot in this tube
Prior to performing BB tests, spin specimen tube for approx. 5 minutes
Use serum for Ab detection & identification
Use the sloughed- / sluffed-off RBCs found at the bottom of this specimen tube for blood typing
Pink top tube (BB specimen)
Contains K2 EDTA - dried form coated along sides of a plastic specimen tube
Does NOT contain the liquid K3 EDTA anticoagulant, commonly used in Hematology analyzers.
Liquid K3, causes a slight dilution in the patient's plasma which may result in the undetection of a low-titer Ab. The Hematology analyzers account for the dilution effect from K3 EDTA tubes when analyzing the CBC.
This EDTA anticoagulant binds Ca^{+2} in the blood and prevents the blood from clotting
Preferred BB sample for all BB testing
Use both plasma & RBCs; must spin down sample
If you need to use a purple top tube from Hematology, ensure you use the K2 EDTA plastic tube…NOT the liquid K3 glass tube.
Blood banking reagents are categorized into 5 basic groups:
Antisera - possess antibodies (Abs) of known specificity
Red Cell Reagent - RBCs that possess antigens of known specificity
Antiglobulin Reagents - detects IgG and / or C' on RBCs
Potentiators / Enhancement Media - reagent use to increase Ab uptake to the corresponding antigen OR enhance RBC agglutination
Lectins - plant extracts that react to specific human RBC antigens
LECTIN | Antigen SPECIFICITY |
---|---|
Dolichos biflorus | A1 |
Ulex europaeus | H |
Vicia graminea | N |
Iberus amara | M |
Arachis hypogae | T Differentiates polyagglutination |
Glycine soja | Tn Differentiates polyagglutination |
Salvia sclarea | |
Salvia horminum |
When using any BB reagents, you must strictly follow these guidelines:
Carefully review the package inserts
Adhere to the package insert instruction for use
Adhere to the manufacturer’s restrictions & precautions - know your reagent's limitations!
IgM - Usually contained in a "saline" media
IgG - Usually contained in a "potentiator" media to enhance reactivity to RBCs OR in a "saline" media to react at the AHG phase of testing (antiglobulin reagent)
IgA - There is no known IgA reagent, at this time
Polyclonal
Usually an immune response
Produced by multiple B-cell lines
Broader specificity due to mixture of antibodies to multiple epitopes.
Monoclonal
Produced by a single B-cell line
Specificity directed at single epitope (best type of reagent)
Identical antibody molecules
Unlimited Production
No human source - animal source Ab usually obtained through hybridoma technology
IgM Ab, so direct agglutination occurs in shorter time
No contaminating Ab(s)
Standardized reagents
Very little or no variation between batches
Used with patient sera to identify patient Abs that are present
Used as "positive" & "negative" controls, when using a specific antisera reagent
For typing a patient's ABO blood type, testing BOTH the patient's RBC & the plasma / serum is required.
The testing scheme terminology using different reagents is known as:
For RBC testing - known as the "Forward" type / group
For the plasma / serum testing - known as the "Reverse" type / group
Performed to detect A or B antigens on RBC membrane:
Always performed:
Unk. RBCs + Anti-A = aggl. ?
Unk. RBCs + Anti-B = aggl. ?
Optionally performed:
Unk. RBCs + Anti-A,B = aggl. ? (subgroups)
Unk. RBCs + Anti-H = aggl. ? (Bombay)
Unk. RBCs + Anti-A1 = aggl. ? (A subgroup)
Lectins : Anti-A1 (Dolichos biflores); Anti-H (Ulex europeous)
Anti-A,B reagent is known as "group O" typing sera; contains anti-A,B of IgG2 subclass
Forward types typically give 4+ reactions, unless subgroup or mixed field
ABO Type | Anti-A | Anti-B | Anti-A,B* |
---|---|---|---|
O | 0 | 0 | 0 |
A | 4+ | 0 | 4+ |
B | 0 | 4+ | 4+ |
AB | 4+ | 4+ | 4+ |
*Anti-A,B use is optional
Performed to detect circulating Abs to A, B, AB, or H
Uses known RBCs (reagent red cells).
Always performed:
Unk serum + A1 cells = aggl. ?
Unk serum + B cells = aggl. ?
Optionally performed:
Unk serum + O cells = aggl. ? (Bombay or unexpected alloantibodies)
Should not be performed on children < 6 mos
All forward / reverse discrepancies must be resolved!
Please note the "order" of adding the reagents:
Add 1 drop of reagent antisera + 1 drop of patient cells; mix; spin; & read
Add 2 drop of patient serum + 1 drop of red cell reagent; mix; spin; & read
Always add the "clear" substance(s) FIRST…this ensures that you've added the reagent (or serum) to the test system.
Always add the "cells" LAST…this accomplishes 3 things:
The reagent / serum was added to the test.
The test is properly setup for serological testing.
A "false" negative test result due to the lack of adding reagent or serum can be avoided.
ABO Type | A1 Cells | B Cells |
---|---|---|
O | 4+ | 4+ |
A | 0 | 4+ |
B | 4+ | 0 |
AB | 0 | 0 |
Blood Group | Anti-A | Anti-B | Anti-A,B | A1 Cells | B Cells |
---|---|---|---|---|---|
O | - | - | - | + | + |
A | + | - | + | - | + |
B | - | + | + | + | - |
AB | + | + | + | - | - |
Aka, isohemagglutinins
Mostly are IgM, i.e., primarily IgMs are found in groups A & B individuals; both IgM & IgG2 subclass found in group O individuals.
Readily binds C'; aka, hemolysins
Usually gives strong (4+) agglutination at IS / RT…Cold to thermo tolerant Abs
IgM does not cross the placenta barrier
“Naturally occurring” - all normal, healthy people have Abs to ABH antigens which they lack
Titers vary, e.g., type O people have higher titers of Anti-A than do B people
May cause serious / fatal incompatible transfusion reactions
May cause severe Hemolytic Disease of the Fetus & Newborn (HDFN); usually seen in group O mothers giving birth to group A neonates
Specificity
Anti-A
Anti-B
Special attributes for group O individuals
Anti-A & anti-B IgMs both present
Anti-A,B (an IgG2 subclass Ab) is also present
Anti-A,B is not a "combination" of each anti-A & anti-B, but rather a single "cross-reacting" IgG Ab unique to Group O types
Before 3 to 6 mos -
Low titers of ABO Abs due to immaturity / undeveloped immune system
Do NOT perform reverse typing on a baby less than 6 mos old
In clinical practice, some hospitals will defer reverse typing until age 1 yr.
By age 5 to 10 - adult levels of Abs are generally reached
> 65 yrs - may have decreased ABO titers due to aging & weakened immune system
| Donor | O- | O+ | A- | A+ | B- | B+ | AB- | AB+ |
| :------ | :- | :- | :- | :- | :- | :- | :-- | :-- |
| Recipient |
| O- | ✓ | × | × | × | × | × | × | × |
| O+ | ✓ | ✓ | × | × | × | × | × | × |
| A- | ✓ | × | ✓ | × | × | × | × | × |
| A+ | ✓ | ✓ | ✓ | ✓ | × | × | × | × |
| B- | ✓ | × | × | × | ✓ | × | × | × |
| B+ | ✓ | ✓ | × | × | ✓ | ✓ | × | × |
| AB- | ✓ | × | ✓ | × | ✓ | × | ✓ | × |
| AB+ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Technical / Clerical errors
RBC reactivity with antisera:
Weak or mixed field
Unexpected reaction
Plasma / serum reactivity with reagent RBCs:
Unexpected reaction
Missing or weak plasma reaction
Type | Reasons | Conditions |
---|---|---|
Group I discrepancy | Weak reacting or missing antibodies. | -Chimerism (due to blood transfusion, transplanted bone marrow, exchange transfusion, feto maternal bleeding) -New born infants. -Elderly patients -Hypogammaglobulinemia (leukemia, immunodeficiency diseases) |
Group II discrepancy | Weak reacting or missing antigens. | -Subgroups of A or B -Leukemia - excess amount of B, -Acquired B phenomenon (in gram negative septicemia, intestinal obstruction and cancer of colon or rectum). |
Group III discrepancy | Protein/ plasma abnormality leading to rouleaux formation | -Elevated globulin level (in multiple myeloma, Waldenstrom' macroglobulinemia, plasma cell dyscrasias, Hodgkin lymphoma). -Plasma expanders like dextran, polyvinyl pyrrolidone -Wharton's jelly (in cord blood) |
Group IV discrepancy | Miscellaneous problems | -Exposure of hidden erythrocyte T antigen (Polyagglutination) -Cold and warm autoantibody (AIHA) -Transfused foreign antigen. -Unexpected ABO iso-agglutinin and alloantibody. -Antibody other than anti-A & anti-B (E.g.: acriflavin antibody) -cis- AB individuals. |
Forward | Reverse | Explanation |
---|---|---|
Missing/Weak | Extra | A/B Subgroup, Acquired B, O Transfusion |
Mixed Field | Young, Elderly, Immunocompromised | |
Missing/Weak | Cold Autoantibody, Disease (cancer) | |
Extra | B(A) Phenotype, Bone Marrow Transplant | |
Cold Alloantibody, Rouleaux | ||
May cause all + reactions | ||
Rouleaux, Anti-A₁ |
ABO Type | Anti-A | Anti-B | Anti-A,B | A1 Cells | B Cells |
---|---|---|---|---|---|
4+ | 0 | 4+ | 1+ | 4+ |
What is the ABO Type?
ABO Type | Anti-A | Anti-B | Anti-A,B | Anti-A1 Lectin |
---|---|---|---|---|
Forward Type | 4+ | 0 | 4+ | 0 |
ABO Type | Anti-A | Anti-B | Anti-A,B | Anti-A1 Lectin | A1 Cells | B Cells |
---|---|---|---|---|---|---|
4+ | 0 | 4+ | 0 | 1+ | 4+ |
Adding the Reverse Type What is the "possible" ABO Type?
ABO Type | Anti-A | Anti-B | Anti-A,B | Anti-A1 Lectin | A1 Cells | B Cells |
---|---|---|---|---|---|---|
4+ | 0 | 4+ | 0 | 1+ | 4+ |
What could be causing the Reverse Grouping problem?
For A subgroup chart - see p 131, Table 6-14
For B subgroup chart - see p 133, Table 6-15